Cargando…
PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042215/ http://dx.doi.org/10.1186/1546-0096-11-S2-P151 |
| _version_ | 1782318773092483072 |
|---|---|
| author | De Benedetti, F Ruperto, N Brunner, HI Grom, A Wulffraat, N Henrickson, M Jerath, R Kimura, Y Kadva, AK Wang, J Martini, A Lovell, D |
| author_facet | De Benedetti, F Ruperto, N Brunner, HI Grom, A Wulffraat, N Henrickson, M Jerath, R Kimura, Y Kadva, AK Wang, J Martini, A Lovell, D |
| author_sort | De Benedetti, F |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4042215 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40422152014-06-17 PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study De Benedetti, F Ruperto, N Brunner, HI Grom, A Wulffraat, N Henrickson, M Jerath, R Kimura, Y Kadva, AK Wang, J Martini, A Lovell, D Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4042215/ http://dx.doi.org/10.1186/1546-0096-11-S2-P151 Text en Copyright © 2013 De Benedetti et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation De Benedetti, F Ruperto, N Brunner, HI Grom, A Wulffraat, N Henrickson, M Jerath, R Kimura, Y Kadva, AK Wang, J Martini, A Lovell, D PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study |
| title | PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study |
| title_full | PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study |
| title_fullStr | PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study |
| title_full_unstemmed | PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study |
| title_short | PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study |
| title_sort | pres-final-2139: tapering and withdrawal of tocilizumab in patients with systemic jia in inactive disease: results from an alternative dosing regimen in the tender study |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042215/ http://dx.doi.org/10.1186/1546-0096-11-S2-P151 |
| work_keys_str_mv | AT debenedettif presfinal2139taperingandwithdrawaloftocilizumabinpatientswithsystemicjiaininactivediseaseresultsfromanalternativedosingregimeninthetenderstudy AT ruperton presfinal2139taperingandwithdrawaloftocilizumabinpatientswithsystemicjiaininactivediseaseresultsfromanalternativedosingregimeninthetenderstudy AT brunnerhi presfinal2139taperingandwithdrawaloftocilizumabinpatientswithsystemicjiaininactivediseaseresultsfromanalternativedosingregimeninthetenderstudy AT groma presfinal2139taperingandwithdrawaloftocilizumabinpatientswithsystemicjiaininactivediseaseresultsfromanalternativedosingregimeninthetenderstudy AT wulffraatn presfinal2139taperingandwithdrawaloftocilizumabinpatientswithsystemicjiaininactivediseaseresultsfromanalternativedosingregimeninthetenderstudy AT henricksonm presfinal2139taperingandwithdrawaloftocilizumabinpatientswithsystemicjiaininactivediseaseresultsfromanalternativedosingregimeninthetenderstudy AT jerathr presfinal2139taperingandwithdrawaloftocilizumabinpatientswithsystemicjiaininactivediseaseresultsfromanalternativedosingregimeninthetenderstudy AT kimuray presfinal2139taperingandwithdrawaloftocilizumabinpatientswithsystemicjiaininactivediseaseresultsfromanalternativedosingregimeninthetenderstudy AT kadvaak presfinal2139taperingandwithdrawaloftocilizumabinpatientswithsystemicjiaininactivediseaseresultsfromanalternativedosingregimeninthetenderstudy AT wangj presfinal2139taperingandwithdrawaloftocilizumabinpatientswithsystemicjiaininactivediseaseresultsfromanalternativedosingregimeninthetenderstudy AT martinia presfinal2139taperingandwithdrawaloftocilizumabinpatientswithsystemicjiaininactivediseaseresultsfromanalternativedosingregimeninthetenderstudy AT lovelld presfinal2139taperingandwithdrawaloftocilizumabinpatientswithsystemicjiaininactivediseaseresultsfromanalternativedosingregimeninthetenderstudy |